Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,748 | -33,662 | -15,523 | -35,816 | -19,808 |
| Depreciation Amortization | 1,141 | 783 | 416 | 439 | 117 |
| Accounts payable and accrued liabilities | -393 | -645 | -78 | 1,072 | 536 |
| Other Working Capital | 11,512 | 3,954 | 993 | -6,470 | -158 |
| Other Operating Activity | 9,486 | 6,250 | 2,609 | 5,085 | 2,215 |
| Operating Cash Flow | $-34,002 | $-23,320 | $-11,583 | $-35,690 | $-17,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,725 | -4,544 | -1,116 | -1,708 | -1,091 |
| Purchase Of Investment | -103,537 | -81,290 | -63,064 | -152,811 | -106,790 |
| Sale Of Investment | 143,697 | 106,691 | 64,086 | 29,250 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 40 | -60 |
| Investing Cash Flow | $33,435 | $20,857 | $-94 | $-125,229 | $-107,941 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 168,119 | 168,117 |
| Other Financing Activity | 801 | 216 | 45 | 67,208 | 67,314 |
| Financing Cash Flow | $801 | $216 | $45 | $235,327 | $235,431 |
| Beginning Cash Position | 76,677 | 76,677 | 76,677 | 2,269 | 2,269 |
| End Cash Position | 76,911 | 74,430 | 65,045 | 76,677 | 112,661 |
| Net Cash Flow | $234 | $-2,247 | $-11,632 | $74,408 | $110,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,002 | -23,320 | -11,583 | -35,690 | -17,098 |
| Capital Expenditure | -6,725 | -4,544 | -1,116 | -1,708 | -1,091 |
| Free Cash Flow | -40,727 | -27,864 | -12,699 | -37,398 | -18,189 |